Stellantis Turnaround Strategy Prediction Market Oversight and Oura IPO Filing Highlight Key Market Developments
Nifty Midcap 100 Hits Record High for Fourth Straight Session Analysts Flag Potential 20 Upside
Title Tech Surge Powers SP 500 Higher as Energy Weighs
Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products
Oil Prices Decline as USIran Talks Spur Hope for Hormuz Strait Deescalation
Kars4Kids Ad Ban in California Highlights Regulatory Risks for Nonprofit Advertising
FUBO Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher
BRZE Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Optimism
DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending
ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat
Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution
XPO Q1 2026 Earnings Earnings Surpass Estimates as Profitability Improves
Blue Bird Corporation BLBD Edges Lower Amid Market Consolidation
QTWO Retreats from Resistance Q2 Holdings Slips 167 as Support Levels Come into Focus
Spectral AI Inc Warrants MDAIW Hold Steady Near Support After Flat Session
Melar Acquisition Corp I Warrant MACIW Holds Near Support Amidst Low Volume Trading
Worthington Enterprises WOR Holds Ground Near Support Amid Modest Pullback
Trump Maintains Iran Naval Blockade Signals No Rush for Deal
WEBTOON Entertainment WBTN Q1 2026 Earnings Loss Narrows Sharply Shares Edge Higher
Banco Bradesco BBD Edges Higher as Support Holds Key Levels to Watch
ROIV Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Pipeline Costs
IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress
Kratos Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Greenidge Generation Holdings 850 Senior Notes GREEL Q1 2025 Earnings Narrowed Loss Exceeds Expectations as Stock Reacts Cautiously
Insperity Q1 2026 Earnings EPS Surpasses Estimates by 511
KHC Q1 2026 Earnings Earnings Beat Boosts Sentiment Amid Revenue Uncertainty
MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress